SC: Completed Trial can't be Remanded for Procedural Lapse Unless Prejudice is Proven || SC: Sessions Courts Cannot Bar Statutory Remission and Commutation Through Special Sentences || SC: Article 311 Bar Inapplicable If Removing Officer Equals Appointing Authority in Status || SC: Contractual Bar Prevents Arbitral Tribunal From Awarding Pre-Reference Interest || SC Frames Guidelines to Prevent POCSO Act Misuse by Parents in Custody Disputes || Delhi HC Directs DLSA to Convey Trial Court’s Encouraging Message and Compensation to POCSO Survivor || Delhi HC: Gravity of UAPA Offence Cannot Justify Prolonged PMLA Detention || Delhi HC Affirms Equestrian Federation's Youth Olympics Selection, Calls for Clearer Norms & Timeline || Delhi HC: Ajeet Bharti Used Caste Superiority to Humiliate Chandrashekhar Azad || Supreme Court: Anti-Suit Injunction Cannot Rest on Speculation of Unenforceable Foreign Decree

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :